ribavirin has been researched along with AIDS, Murine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchamp, D; Bergeron, MG; Désormeaux, A; Dusserre, N; Gourde, P; Harvie, P; Omar, RF; Tremblay, M | 1 |
| Beauchamp, D; Bergeron, MG; Désormeaux, A; Dusserre, N; Gourde, P; Harvie, P; Lansac, N; Omar, RF; Simard, M; Tremblay, M | 1 |
| Beauchamp, D; Bergeron, MG; Désormeaux, A; Gourde, P; Harvie, P; Omar, RF; Tremblay, M | 1 |
3 other study(ies) available for ribavirin and AIDS, Murine
| Article | Year |
|---|---|
Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Blood Cell Count; CD4-CD8 Ratio; Cell Division; Concanavalin A; Disease Models, Animal; Female; Immunoglobulin M; Leukemia Virus, Murine; Lymph Nodes; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Organ Size; Ribavirin; Spleen | 1996 |
Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.
Topics: Animals; Antiviral Agents; CD4-CD8 Ratio; Didanosine; Drug Synergism; Drug Therapy, Combination; Female; Immunoglobulin M; Lymphatic Diseases; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Ribavirin; Splenomegaly | 1996 |
Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model.
Topics: Animals; Antiviral Agents; Drug Therapy, Combination; Epithelium; Foscarnet; Hematologic Tests; Immunoglobulin M; Kidney Tubules; Lymph Nodes; Mice; Mice, Inbred C57BL; Microscopy, Electron; Murine Acquired Immunodeficiency Syndrome; Organ Size; Ribavirin; Spleen | 1997 |